These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 21125461

  • 21. Clazosentan (Actelion).
    Uhlmann D.
    Curr Opin Investig Drugs; 2006 Mar; 7(3):272-81. PubMed ID: 16555688
    [Abstract] [Full Text] [Related]

  • 22. Impact of global cerebral atrophy on clinical outcome after subarachnoid hemorrhage.
    Tam AK, Kapadia A, Ilodigwe D, Li Z, Schweizer TA, Macdonald RL.
    J Neurosurg; 2013 Jul; 119(1):198-206. PubMed ID: 23662822
    [Abstract] [Full Text] [Related]

  • 23. The effectiveness and safety of clazosentan in treating aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
    Al-Salihi MM, Saha R, Abd Elazim A, Helal A, Sabah Al-Jebur M, Al-Salihi Y, Ayyad A.
    J Clin Neurosci; 2024 Aug; 126():173-181. PubMed ID: 38924824
    [Abstract] [Full Text] [Related]

  • 24. Dissociation of vasospasm and secondary effects of experimental subarachnoid hemorrhage by clazosentan.
    Sabri M, Ai J, Macdonald RL.
    Stroke; 2011 May; 42(5):1454-60. PubMed ID: 21454820
    [Abstract] [Full Text] [Related]

  • 25. Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.
    Tam AK, Ilodigwe D, Mocco J, Mayer S, Kassell N, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL.
    Neurocrit Care; 2010 Oct; 13(2):182-9. PubMed ID: 20593247
    [Abstract] [Full Text] [Related]

  • 26. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study.
    Pearl JD, Macdonald RL.
    Acta Neurochir Suppl; 2008 Oct; 105():207-10. PubMed ID: 19066110
    [Abstract] [Full Text] [Related]

  • 27. The effect of endothelin receptor antagonists on vasospasm following aneurysmal subarachnoid hemorrhage.
    Komotar RJ, Starke RM, Connolly ES.
    Neurosurgery; 2011 Dec; 69(6):N13-4. PubMed ID: 22067343
    [No Abstract] [Full Text] [Related]

  • 28. Different Doses of Clazosentan for Aneurismal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.
    Rong WL, Xiao X, Zhao JL, Yang XW, Hu ZL, Li MH.
    Am J Ther; 2018 Dec; 25(6):e652-e660. PubMed ID: 26752653
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Patient phenotypes associated with outcomes after aneurysmal subarachnoid hemorrhage: a principal component analysis.
    Ibrahim GM, Morgan BR, Macdonald RL.
    Stroke; 2014 Mar; 45(3):670-6. PubMed ID: 24425125
    [Abstract] [Full Text] [Related]

  • 31. Clazosentan for patients with subarachnoid haemorrhage: lessons learned.
    Wong GK, Poon WS.
    Lancet Neurol; 2011 Oct; 10(10):871; author reply 871-2. PubMed ID: 21939894
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
    Vergouwen MD, Algra A, Rinkel GJ.
    Stroke; 2012 Oct; 43(10):2671-6. PubMed ID: 22871682
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clazosentan: First Approval.
    Lee A.
    Drugs; 2022 Apr; 82(6):697-702. PubMed ID: 35362854
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
    Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O, Tominaga T.
    J Neurosurg; 2022 Dec 01; 137(6):1707-1717. PubMed ID: 35364589
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.
    Pisapia JM, Xu X, Kelly J, Yeung J, Carrion G, Tong H, Meghan S, El-Falaky OM, Grady MS, Smith DH, Zaitsev S, Muzykantov VR, Stiefel MF, Stein SC.
    Exp Neurol; 2012 Jan 01; 233(1):357-63. PubMed ID: 22079156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.